James M. Gower
2008
In 2008, James M. Gower earned a total compensation of $3.7M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 106% increase compared to previous year.
Compensation breakdown
| Option Awards | $3,138,614 |
|---|---|
| Salary | $600,000 |
| Other | $3,712 |
| Total | $3,742,326 |
Gower received $3.1M in option awards, accounting for 84% of the total pay in 2008.
Gower also received $600K in salary and $3.7K in other compensation.
Rankings
In 2008, James M. Gower's compensation ranked 1,235th out of 9,135 executives tracked by ExecPay. In other words, Gower earned more than 86.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,235 out of 9,135 | 87th |
Division Manufacturing | 451 out of 3,436 | 87th |
Major group Chemicals And Allied Products | 85 out of 815 | 90th |
Industry group Drugs | 53 out of 597 | 91st |
Industry Pharmaceutical Preparations | 42 out of 408 | 90th |
Source: SEC filing on April 4, 2011.
Gower's colleagues
We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2008.
2008
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2008
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2008
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2008
Ryan Maynard
Rigel Pharmaceuticals